<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Nevirapine</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Nevirapine">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Nevirapine</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Nevirapine</b> (<b>NVP</b>), marketed under the trade name <b>Viramune</b> among others, is a medication used to treat and prevent HIV/AIDS, specifically HIV-1.<span class="mw-ref" id="cite_ref-AHFS2016_1-0"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is generally recommended for use with other antiretroviral medication.<span class="mw-ref" id="cite_ref-AHFS2016_1-1"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It may be used to prevent mother to child spread during birth but is not recommended following other exposures.<span class="mw-ref" id="cite_ref-AHFS2016_1-2"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is taken by mouth.<span class="mw-ref" id="cite_ref-AHFS2016_1-3"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Nevirapine</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Nevirapine.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Nevirapine.svg.png" data-file-width="512" data-file-height="479" data-file-type="drawing" height="206" width="220"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Nevirapine_3D_balls_1fkp.png" tppabs="https://ptable.com/wiki/compounds/I/m/Nevirapine_3D_balls_1fkp.png" data-file-width="1200" data-file-height="1027" data-file-type="bitmap" height="188" width="220"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Viramune</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/nevirapine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/nevirapine.html'" tppabs="https://www.drugs.com/monograph/nevirapine.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a600035.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a600035.html'" tppabs="https://medlineplus.gov/druginfo/meds/a600035.html" class="external text external">a600035</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Nevirapine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Nevirapine'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Nevirapine" class="external text external">by INN</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">

<ul><li>B: (USA)</li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>J05AG01<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=J05AG01  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=J05AG01'" tppabs="https://www.whocc.no/atc_ddd_index/?code=J05AG01" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>93% ± 9%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>45 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Kidney: &lt;6% (Parent drug) <br> Biliary &lt;5% (Parent drug)</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">11-cyclopropyl-4-methyl-5,11-dihydro-6<i>H</i>- dipyrido[3,2-<i>b</i>:2′,3′-<i>e</i>][1,4]diazepin-6-one</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=129618-40-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=129618-40-2'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=129618-40-2" class="external text external">129618-40-2</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/4463  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/4463'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/4463" class="external text external">4463</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00238  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00238'" tppabs="https://www.drugbank.ca/drugs/DB00238" class="external text external">DB00238</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.4308.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.4308.html'" tppabs="http://www.chemspider.com/Chemical-Structure.4308.html" class="external text external">4308</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=99DK7FVK1H  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=99DK7FVK1H'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=99DK7FVK1H" class="external text external">99DK7FVK1H</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D00435  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D00435'" tppabs="https://www.kegg.jp/entry/D00435" class="external text external">D00435</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL57  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL57'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL57" class="external text external">ChEMBL57</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">NIAID ChemDB</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=001856  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=001856'" tppabs="https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=001856" class="external text external">001856</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID7031797  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID7031797'" tppabs="https://comptox.epa.gov/dashboard/DTXSID7031797" class="external text external">DTXSID7031797</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.117.250  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.117.250'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.117.250" class="external text external">100.117.250</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>15</sub><span>H</span><sub>14</sub><span>N</span><sub>4</sub><span>O</span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">266.304</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC2Nc1c%28ccnc1N%28c3ncccc23%29C4CC4%29C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC2Nc1c%28ccnc1N%28c3ncccc23%29C4CC4%29C'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC2Nc1c%28ccnc1N%28c3ncccc23%29C4CC4%29C" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C2Nc1c(ccnc1N(c3ncccc23)C4CC4)C</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:NQDJXKOVJZTUJA-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462259855&page2=Nevirapine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462259855&page2=Nevirapine'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462259855&page2=Nevirapine" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Common side effects include rash, headache, nausea, feeling tired, and liver problems.<span class="mw-ref" id="cite_ref-AHFS2016_1-4"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> The liver problems and skin rash may be severe and should be checked for during the first few months of treatment.<span class="mw-ref" id="cite_ref-AHFS2016_1-5"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Ric2015_2-0"><a href="#cite_note-Ric2015-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It appears to be safe for use during pregnancy.<span class="mw-ref" id="cite_ref-AHFS2016_1-6"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and works by blocking the function of reverse transcriptase.<span class="mw-ref" id="cite_ref-AHFS2016_1-7"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


<p>Nevirapine was approved for medical use in the United States in 1996.<span class="mw-ref" id="cite_ref-AHFS2016_1-8"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.<span class="mw-ref" id="cite_ref-WHO21st_3-0"><a href="#cite_note-WHO21st-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It is available as a generic medication.<span class="mw-ref" id="cite_ref-AHFS2016_1-9"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Nevirapine is used in adults and in children 6 years of age infected with HIV-1 as part of combination antiretroviral treatment (ART or cART). Monotherapy with nevirapine is not indicated due to rapid emergence of resistance.<span class="mw-ref" id="cite_ref-:0_4-0"><a href="#cite_note-:0-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p>Nevirapine in triple combination therapy has been shown to suppress viral load effectively when used as initial antiretroviral therapy (<i>i.e.</i>, in antiretroviral-naive patients).<span class="mw-ref" id="cite_ref-INCAS_1998_5-0"><a href="#cite_note-INCAS_1998-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Some clinical trials have demonstrated comparable HIV suppression with nevirapine-based regimens to that achieved with regimens based on a protease inhibitor (PI)<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> or <a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">efavirenz</a>.<span class="mw-ref" id="cite_ref-2NN_8-0"><a href="#cite_note-2NN-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<p>This drug is generally only to be considered for use if the CD4 cell count is very low.<span class="mw-ref" id="cite_ref-:0_4-1"><a href="#cite_note-:0-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p>Although concerns have been raised about nevirapine-based regimens in those starting therapy with high viral load or low CD4 count, some analyses suggest that nevirapine may be effective in this group of people.<span class="mw-ref" id="cite_ref-2NN_8-1"><a href="#cite_note-2NN-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<p>Nevirapine may also form a useful component of salvage regimens after virological failure, usually in combination with one or more PIs as well as nucleotide reverse transcriptase inhibitor (NRTIs), especially in those who have not previously taken an NNRTI.</p>

<p>Dosing in children is based on body surface area (BSA),<span class="mw-ref" id="cite_ref-:0_4-2"><a href="#cite_note-:0-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> however, weight-based dosing algorithms have been released. These guidelines include dosing algorithms for as young as newborn babies.<span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Preventing_mother-to-child_transmission">Preventing mother-to-child transmission</h3></summary>
    

<p>A single dose of nevirapine given to both mother and child reduced the rate of HIV transmission by almost 50% compared with a very short course of <a href="Zidovudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Zidovudine" title="Zidovudine">zidovudine</a> (AZT) prophylaxis, in a clinical trial in Uganda.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> A subsequent study in Thailand showed that prophylaxis with single-dose nevirapine in addition to zidovudine is more effective than zidovudine alone.<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> These and other trials have led the World Health Organization to endorse the use of single-dose nevirapine prophylaxis in many developing world settings as a cost-effective way of reducing mother-to-child transmission. However, in the United States the Ugandan study was deemed flawed <span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> and as of 2006 the FDA has not approved of such nevirapine prophylaxis.<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> However, supporters of HIVNET 012 experiment argued that the flaws in this experiment were largely due to bureaucratic incompetence, while the findings regarding the safety and efficacy of single-dose nevirapine from this study were scientifically solid and too important to discard.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> Moreover, it was argued that holding African researchers who operated under resource-poor situations to the same moral and procedural standards to their Western counterparts was unrealistic, and would further marginalize African researchers' role in the science community and impede the progress of African science.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Another clinical trial, <i>Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding</i>, was completed in September 2013.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>  	

<p>A major concern with this approach is that NNRTI resistance mutations are commonly observed in both mothers and infants after single-dose nevirapine,<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> and may compromise the response to future NNRTI-containing regimens.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> A short course of maternal zidovudine/lamivudine is recommended by the U.S. Public Health Service Task Force to reduce this risk.<span class="mw-ref" id="cite_ref-perinatal_19-0"><a href="#cite_note-perinatal-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    

<p>The most common adverse effect of nevirapine is the development of mild or moderate rash (13%).<span class="mw-ref" id="cite_ref-PInfo_20-0"><a href="#cite_note-PInfo-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-ATDN_21-0"><a href="#cite_note-ATDN-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> Severe or life-threatening skin reactions have been observed in 1.5% of patients, including Stevens–Johnson syndrome, toxic epidermal necrolysis and hypersensitivity.<span class="mw-ref" id="cite_ref-PInfo_20-1"><a href="#cite_note-PInfo-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>

<p>Nevirapine may cause severe or life-threatening liver toxicity, usually emerging in the first six weeks of treatment.<span class="mw-ref" id="cite_ref-PInfo_20-2"><a href="#cite_note-PInfo-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-dhhs_22-0"><a href="#cite_note-dhhs-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> In 2000, the U.S. Food and Drug Administration issued a black box warning on nevirapine, warning that it could cause life-threatening liver toxicity and skin reactions.<span class="mw-ref" id="cite_ref-:1_23-0"><a href="#cite_note-:1-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> Unacceptably high risk of serious liver symptoms in certain patient groups (women with CD4 count <span>&gt;</span>250 and men <span>&gt;</span>400)<span class="mw-ref" id="cite_ref-2NN_8-2"><a href="#cite_note-2NN-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> has led the U.S. DHHS to recommend the restriction of nevirapine use to those at lower risk, unless the benefit to the patient clearly outweighs the risk;<span class="mw-ref" id="cite_ref-dhhs_22-1"><a href="#cite_note-dhhs-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> although in the 2NN study which found these CD4 limits, the effect was seen only in patients recruited from Thailand. More recent studies on the use of Nevirapine in people with higher CD4 cell counts have come to the following conclusion: Treatment-experienced patients who start NVP-based combination therapy with low pre–ART and high current CD4 cell counts and an undetectable VL have a similar likelihood for discontinuing NVP therapy because of hypersensitivity reactions (HSRs), compared with treatment-naive patients with low CD4 cell counts. This suggests that NVP-based combination therapy may be safely initiated in such patients. However, in similar patients with a detectable VL, it is prudent to continue to adhere to current CD4 cell count thresholds.<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> The U.S. Public Health Service Task Force advocates caution in the use of nevirapine in pregnancy due to toxicity issues, which may be exacerbated during pregnancy.<span class="mw-ref" id="cite_ref-perinatal_19-1"><a href="#cite_note-perinatal-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>

<p>Cases of immune reconstitution syndrome and fat redistribution have also been observed with this drug.<span class="mw-ref" id="cite_ref-:1_23-1"><a href="#cite_note-:1-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>

<p>The U.S. Food and Drug Administration recommends stopping nevirapine if a person experiences:<span class="mw-ref" id="cite_ref-:1_23-2"><a href="#cite_note-:1-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>
<ul><li>sign and symptoms of liver issues such as hepatitis</li>
<li>increased transaminases in addition to rash or systemic symptoms</li>
<li>formation of rash with systemic symptoms</li>
<li>severe skin or hypersensitivity reactions</li></ul>
<p>Additionally, the U.S. FDA recommends close monitoring during the first 6 weeks of therapy for the above symptoms as there is high risk during this time. Continued monitoring is recommended for up to the first 18 weeks of treatment. If a patient experiences hepatitis plus rash or other systemic symptoms, or severe hypersensitivity or skin rash, nevirapine should not be restarted.<span class="mw-ref" id="cite_ref-:1_23-3"><a href="#cite_note-:1-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Drug_interactions">Drug interactions</h2></summary>
    
<p>Nevirapine is a substrate for liver CYP3A and CYP2B6 enzymes. Concomitant administration of drugs that are inhibitors of these enzymes may increase serum nevirapine levels significantly. Some examples of these drugs include <a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">ritonavir</a>, <a href="Fosamprenavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosamprenavir" title="Fosamprenavir">fosamprenavir</a>, and <a href="Fluconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluconazole" title="Fluconazole">fluconazole</a>. On the other hand, drugs that are inducers of these enzymes such as <a href="Rifampicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rifampicin" title="Rifampicin">rifampicin</a> may lower serum nevirapine levels.<span class="mw-ref" id="cite_ref-:02_26-0"><a href="#cite_note-:02-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><sup><a href="#cite_note-PInfo-18" title="Nevirapine">[18]</a></sup></p>

<p>In addition, concomitant use of  St. John's wort <i>(Hypericum perforatum</i>, which has been shown to induce CYP3A4 and CYP1A2<span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span>) or St. John's wort containing products may significantly lower nevirapine levels.<span class="mw-ref" id="cite_ref-:02_26-1"><a href="#cite_note-:02-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span></p>

<p>Nevirapine is an inducer of cytochrome P450 isoenzymes CYP3A4 and CYP2B6. It may reduce levels of several co-administered drugs including the antiretrovirals <a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">efavirenz</a>, <a href="Indinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Indinavir" title="Indinavir">indinavir</a>, <a href="Lopinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Lopinavir" title="Lopinavir">lopinavir</a>, <a href="Nelfinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Nelfinavir" title="Nelfinavir">nelfinavir</a> and <a href="Saquinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Saquinavir" title="Saquinavir">saquinavir</a>, as well as <a href="Clarithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clarithromycin" title="Clarithromycin">clarithromycin</a>, <a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">ketoconazole</a>, forms of hormonal contraception, and <a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">methadone</a>.<span class="mw-ref" id="cite_ref-PInfo_20-3"><a href="#cite_note-PInfo-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism_of_action">Mechanism of action</h2></summary>
    
<div class="thumb tleft"><div class="thumbinner" style="width:222px"><img src="../I/m/Nevirapine_3D.png" tppabs="https://ptable.com/wiki/compounds/I/m/Nevirapine_3D.png" data-file-width="640" data-file-height="480" data-file-type="bitmap" height="165" width="220"><div class="thumbcaption" style="text-align: left">Nevirapine shown in ball and stick structure.</div></div></div>
<p>Nevirapine falls in the non-nucleoside reverse transcriptase inhibitor (NNRTI) class of antiretrovirals.<span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span>  Both nucleoside and non-nucleoside RTIs inhibit the same target, the reverse transcriptase enzyme, an essential viral enzyme which transcribes viral RNA into DNA. Unlike nucleoside RTIs, which bind at the polymerase active site, NNRTIs bind to a hydrophobic pocket in the subdomain of p66 which is about 10 angstrom away from the active site (known as the NNRTI pocket). Therefore, this NNRTI-binding pocket will inhibit reverse transcription in a way that is distinct to the NRTIs.<span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>

<p>Nevirapine is not effective against HIV-2, as the pocket of the HIV-2 reverse transcriptase has a different structure, which confers intrinsic resistance to the NNRTI class.<span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>

<p>Resistance to nevirapine develops rapidly if viral replication is not completely suppressed.<span class="mw-ref" id="cite_ref-INCAS_1998_5-1"><a href="#cite_note-INCAS_1998-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> The most common mutations observed after nevirapine treatment are Y181C and K103N, which are also observed with other NNRTIs.<span class="mw-ref" id="cite_ref-PInfo_20-4"><a href="#cite_note-PInfo-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-31"><a href="#cite_note-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> As all NNRTIs bind within the same pocket, viral strains which are resistant to nevirapine are usually also resistant to the other NNRTIs, <a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">efavirenz</a> and <a href="Delavirdine.htm" tppabs="https://ptable.com/wiki/compounds/A/Delavirdine" title="Delavirdine">delavirdine</a>. However, second generation NNRTIs like rilpivirine and etravirine are effective in treatment for HIV strains resistant to nevirapine and other first generation drugs in that same class.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Nevirapine was discovered by Karl D. Hargrave and colleagues at Boehringer Ingelheim Pharmaceuticals, Inc., one of the Boehringer Ingelheim group of companies. It is covered by <a href="javascript:if(confirm('http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=5366972.PN.&OS=PN/5366972&RS=PN/5366972  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=5366972.PN.&OS=PN/5366972&RS=PN/5366972'" tppabs="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=5366972.PN.&OS=PN/5366972&RS=PN/5366972" class="external text external">U.S. Patent 5,366,972</a> and corresponding foreign patents.  Nevirapine was the first NNRTI approved by the U.S. Food and Drug Administration (FDA). It was approved June 21, 1996 for adults and September 11, 1998 for children. It was also approved in Europe in 1997.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    
<p>Former U.S. President George W. Bush's PEPFAR funding of $500 million to help combat the African AIDS epidemic included nevirapine, among other medications and programs.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-AHFS2016-1"> <span id="mw-reference-text-cite_note-AHFS2016-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/nevirapine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/nevirapine.html'" tppabs="https://www.drugs.com/monograph/nevirapine.html" class="external text external">"Nevirapine"</a>. The American Society of Health-System Pharmacists. <a href="javascript:if(confirm('https://web.archive.org/web/20161220121202/https://www.drugs.com/monograph/nevirapine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161220121202/https://www.drugs.com/monograph/nevirapine.html'" tppabs="https://web.archive.org/web/20161220121202/https://www.drugs.com/monograph/nevirapine.html" class="external text external">Archived</a> from the original on 20 December 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">3 December</span> 2016</span>.</cite></span></li><li id="cite_note-Ric2015-2"> <span id="mw-reference-text-cite_note-Ric2015-2" class="mw-reference-text"><cite id="CITEREFHamilton2015" class="citation book cs1">Hamilton, Richart (2015). <i>Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition</i>. Jones &amp; Bartlett Learning. p.<span>&nbsp;</span>63. ISBN<span>&nbsp;</span><bdi>9781284057560</bdi>.</cite></span></li><li id="cite_note-WHO21st-3"> <span id="mw-reference-text-cite_note-WHO21st-3" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2019" class="citation book cs1">World Health Organization (2019). <i>World Health Organization model list of essential medicines: 21st list 2019</i>. Geneva: World Health Organization. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10665%2F325771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F325771'" tppabs="https://hdl.handle.net/10665%2F325771" class="external text external">10665/325771</a></span>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</cite></span></li><li id="cite_note-:0-4"> <span id="mw-reference-text-cite_note-:0-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020636s044,020933s035lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020636s044,020933s035lbl.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020636s044,020933s035lbl.pdf" class="external text external">"Product Information: VIRAMUNE(R)XR oral extended-release tablets, nevirapine oral extended-release tablets"</a> <span class="cs1-format">(PDF)</span>. Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, 2011. 2011. <a href="javascript:if(confirm('https://web.archive.org/web/20161106125656/http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020636s044,020933s035lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161106125656/http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020636s044,020933s035lbl.pdf'" tppabs="https://web.archive.org/web/20161106125656/http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020636s044,020933s035lbl.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 2016-11-06<span class="reference-accessdate">. Retrieved <span class="nowrap">2016-11-05</span></span>.</cite></span></li><li id="cite_note-INCAS_1998-5"> <span id="mw-reference-text-cite_note-INCAS_1998-5" class="mw-reference-text"><cite id="CITEREFMontanerReissCooper1998" class="citation journal cs1">Montaner JS, Reiss P, Cooper D (Mar 1998). <a href="javascript:if(confirm('https://doi.org/10.1001/jama.279.12.930  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001/jama.279.12.930'" tppabs="https://doi.org/10.1001/jama.279.12.930" class="external text external">"A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study"</a>. <i>JAMA</i>. <b>279</b> (12): 930–7. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.279.12.930  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.279.12.930'" tppabs="https://doi.org/10.1001%2Fjama.279.12.930" class="external text external">10.1001/jama.279.12.930</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9544767  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9544767'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9544767" class="external text external">9544767</a>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite id="CITEREFvan_LeeuwenKatlamaMurphy2003" class="citation journal cs1">van Leeuwen R, Katlama C, Murphy RL (May 2003). "A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients". <i>AIDS</i>. <b>17</b> (7): 987–99. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00002030-200305020-00007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00002030-200305020-00007'" tppabs="https://doi.org/10.1097%2F00002030-200305020-00007" class="external text external">10.1097/00002030-200305020-00007</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12700448  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12700448'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12700448" class="external text external">12700448</a>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFPodzamczerFerrerConsiglio2002" class="citation journal cs1">Podzamczer D, Ferrer E, Consiglio E (2002). "A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study)". <i>Antiviral Therapy</i>. <b>7</b> (2): 81–90. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12212928  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12212928'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12212928" class="external text external">12212928</a>.</cite></span></li><li id="cite_note-2NN-8"> <span id="mw-reference-text-cite_note-2NN-8" class="mw-reference-text"><cite id="CITEREFvan_LethAndrewsGrinsztejn2005" class="citation journal cs1">van Leth F, Andrews S, Grinsztejn B (Mar 2005). "The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART". <i>AIDS</i>. <b>19</b> (5): 463–71. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F01.aids.0000162334.12815.5b  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F01.aids.0000162334.12815.5b'" tppabs="https://doi.org/10.1097%2F01.aids.0000162334.12815.5b" class="external text external">10.1097/01.aids.0000162334.12815.5b</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15764851  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15764851'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15764851" class="external text external">15764851</a>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://aidsinfo.nih.gov/guidelines  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://aidsinfo.nih.gov/guidelines'" tppabs="http://aidsinfo.nih.gov/guidelines" class="external text external">"Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children: Guidelines for the use of antiretroviral agents in pediatric HIV infection"</a>. AIDSinfo, U.S. Department of Health and Human Services (HHS). March 2016. <a href="javascript:if(confirm('https://web.archive.org/web/20161107221758/https://aidsinfo.nih.gov/guidelines  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161107221758/https://aidsinfo.nih.gov/guidelines'" tppabs="https://web.archive.org/web/20161107221758/https://aidsinfo.nih.gov/guidelines" class="external text external">Archived</a> from the original on 2016-11-07<span class="reference-accessdate">. Retrieved <span class="nowrap">2016-11-05</span></span>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite id="CITEREFGuayMusokeFleming1999" class="citation journal cs1">Guay LA, Musoke P, Fleming T (Sep 1999). "Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial". <i>Lancet</i>. <b>354</b> (9181): 795–802. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2899%2980008-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2899%2980008-7'" tppabs="https://doi.org/10.1016%2FS0140-6736%2899%2980008-7" class="external text external">10.1016/S0140-6736(99)80008-7</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10485720  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10485720'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10485720" class="external text external">10485720</a>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><a href="javascript:if(confirm('http://content.nejm.org/cgi/content/full/351/3/217  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://content.nejm.org/cgi/content/full/351/3/217'" tppabs="http://content.nejm.org/cgi/content/full/351/3/217" class="external text external">Lallemant M, Gonzague Jourdain G, Sophie Le Coeur S, <i>et al.</i> (2004) Single-Dose Perinatal Nevirapine plus Standard Zidovudine to Prevent Mother-to-Child Transmission of HIV-1 in Thailand. <i>N Engl J Med</i> 351: 217-28</a> <a href="javascript:if(confirm('https://web.archive.org/web/20060618192711/http://content.nejm.org/cgi/content/full/351/3/217  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20060618192711/http://content.nejm.org/cgi/content/full/351/3/217'" tppabs="https://web.archive.org/web/20060618192711/http://content.nejm.org/cgi/content/full/351/3/217" class="external text external">Archived</a><span> 2006-06-18 at the </span>Wayback Machine</span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text">The HIVNET 012 Study and the Safety and Effectiveness of Nevirapine in Preventing Mother-to-Infant Transmission of HIV, <cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20090201162348/http://www3.niaid.nih.gov/news/newsreleases/2004/hivnet012.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090201162348/http://www3.niaid.nih.gov/news/newsreleases/2004/hivnet012.htm'" tppabs="https://web.archive.org/web/20090201162348/http://www3.niaid.nih.gov/news/newsreleases/2004/hivnet012.htm" class="external text external">"Archived copy"</a>. Archived from <a href="javascript:if(confirm('http://www3.niaid.nih.gov/news/newsreleases/2004/hivnet012.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www3.niaid.nih.gov/news/newsreleases/2004/hivnet012.htm'" tppabs="http://www3.niaid.nih.gov/news/newsreleases/2004/hivnet012.htm" class="external text external">the original</a> on 2009-02-01<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-01-23</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (link)</span></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text">Celia Farber, "Out of Control: AIDS and the Corruption of Science" <cite class="citation web cs1"><a href="javascript:if(confirm('http://www.harpers.org/archive/2006/03/0080961  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.harpers.org/archive/2006/03/0080961'" tppabs="http://www.harpers.org/archive/2006/03/0080961" class="external text external">"Archived copy"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20090504174126/http://www.harpers.org/archive/2006/03/0080961  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090504174126/http://www.harpers.org/archive/2006/03/0080961'" tppabs="https://web.archive.org/web/20090504174126/http://www.harpers.org/archive/2006/03/0080961" class="external text external">Archived</a> from the original on 2009-05-04<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-06-11</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (link)</span></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text">Crane, J 2010, 'Adverse events and placebo effects: African scientists, HIV, and ethics in the 'global health sciences<i>, Social Studies Of Science, 40, 6, pp. 843-870 <a href="javascript:if(confirm('http://sss.sagepub.com.ezp.lib.unimelb.edu.au/content/40/6/843.full.pdf+html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://sss.sagepub.com.ezp.lib.unimelb.edu.au/content/40/6/843.full.pdf+html'" tppabs="http://sss.sagepub.com.ezp.lib.unimelb.edu.au/content/40/6/843.full.pdf+html" class="external free external">http://sss.sagepub.com.ezp.lib.unimelb.edu.au/content/40/6/843.full.pdf+html</a></i></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text">Lock, M. &amp; Nguyen, V 2010, an Anthropology of Biomedicine, Malden, Wiley-Blackwell.</span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://clinicaltrials.gov/show/NCT00074412  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://clinicaltrials.gov/show/NCT00074412'" tppabs="http://clinicaltrials.gov/show/NCT00074412" class="external text external">"Archived copy"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20081205094051/http://clinicaltrials.gov/show/NCT00074412  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20081205094051/http://clinicaltrials.gov/show/NCT00074412'" tppabs="https://web.archive.org/web/20081205094051/http://clinicaltrials.gov/show/NCT00074412" class="external text external">Archived</a> from the original on 2008-12-05<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-01-23</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (link)</span></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite id="CITEREFJohnsonLiMorris2005" class="citation journal cs1">Johnson JA, Li JF, Morris L (Jul 2005). <a href="javascript:if(confirm('https://doi.org/10.1086/430741  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086/430741'" tppabs="https://doi.org/10.1086/430741" class="external text external">"Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated"</a>. <i>J Infect Dis</i>. <b>192</b> (1): 16–23. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1086%2F430741  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086%2F430741'" tppabs="https://doi.org/10.1086%2F430741" class="external text external">10.1086/430741</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15942889  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15942889'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15942889" class="external text external">15942889</a>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite id="CITEREFJourdainNgo-Giang-HuongLe_Coeur2004" class="citation journal cs1">Jourdain G, Ngo-Giang-Huong N, Le Coeur S (Jul 2004). "Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy". <i>N Engl J Med</i>. <b>351</b> (3): 229–40. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMoa041305  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMoa041305'" tppabs="https://doi.org/10.1056%2FNEJMoa041305" class="external text external">10.1056/NEJMoa041305</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15247339  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15247339'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15247339" class="external text external">15247339</a>.</cite></span></li><li id="cite_note-perinatal-19"> <span id="mw-reference-text-cite_note-perinatal-19" class="mw-reference-text">Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. <cite class="citation web cs1"><a href="javascript:if(confirm('http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf'" tppabs="http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf" class="external text external">"Archived copy"</a> <span class="cs1-format">(PDF)</span>. <a href="javascript:if(confirm('https://web.archive.org/web/20140412004422/http://aidsinfo.nih.gov/contentfiles/lvguidelines/perinatalgl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140412004422/http://aidsinfo.nih.gov/contentfiles/lvguidelines/perinatalgl.pdf'" tppabs="https://web.archive.org/web/20140412004422/http://aidsinfo.nih.gov/contentfiles/lvguidelines/perinatalgl.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 2014-04-12<span class="reference-accessdate">. Retrieved <span class="nowrap">2014-04-11</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (link)</span>. Accessed 16 November 2016.</span></li><li id="cite_note-PInfo-20"> <span id="mw-reference-text-cite_note-PInfo-20" class="mw-reference-text"><a href="javascript:if(confirm('http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing+Information/PIs/Viramune/Viramune.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing+Information/PIs/Viramune/Viramune.pdf'" tppabs="http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing+Information/PIs/Viramune/Viramune.pdf" class="external text external">Viramune (nevirapine) tablets; Viramune (nevirapine) oral suspension prescribing information</a> <a href="javascript:if(confirm('https://web.archive.org/web/20061112162204/http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=%2FPrescribing+Information%2FPIs%2FViramune%2FViramune.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20061112162204/http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=%2FPrescribing+Information%2FPIs%2FViramune%2FViramune.pdf'" tppabs="https://web.archive.org/web/20061112162204/http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=%2FPrescribing+Information%2FPIs%2FViramune%2FViramune.pdf" class="external text external">Archived</a><span> 2006-11-12 at the </span>Wayback Machine</span></li><li id="cite_note-ATDN-21"> <span id="mw-reference-text-cite_note-ATDN-21" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20060113014541/http://www.aegis.com/factshts/network/simple/nevi.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20060113014541/http://www.aegis.com/factshts/network/simple/nevi.html'" tppabs="https://web.archive.org/web/20060113014541/http://www.aegis.com/factshts/network/simple/nevi.html" class="external text external">"Facts sheet from the AIDS Treatment Data Network"</a>. Archived from <a href="javascript:if(confirm('http://www.aegis.com/factshts/network/simple/nevi.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.aegis.com/factshts/network/simple/nevi.html'" tppabs="http://www.aegis.com/factshts/network/simple/nevi.html" class="external text external">the original</a> on 2006-01-13<span class="reference-accessdate">. Retrieved <span class="nowrap">2006-01-16</span></span>.</cite></span></li><li id="cite_note-dhhs-22"> <span id="mw-reference-text-cite_note-dhhs-22" class="mw-reference-text">DHHS panel. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (May 4, 2006). (Available for download from <a href="javascript:if(confirm('http://www.aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=7&ClassID=1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=7&ClassID=1'" tppabs="http://www.aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=7&ClassID=1" class="external text external">AIDSInfo</a> <a href="javascript:if(confirm('https://web.archive.org/web/20060506193229/http://aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=7&ClassID=1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20060506193229/http://aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=7&ClassID=1'" tppabs="https://web.archive.org/web/20060506193229/http://aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=7&ClassID=1" class="external text external">Archived</a><span> 2006-05-06 at the </span>Wayback Machine)</span></li><li id="cite_note-:1-23"> <span id="mw-reference-text-cite_note-:1-23" class="mw-reference-text"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201152s004lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201152s004lbl.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201152s004lbl.pdf" class="external text external">Viramune XR (nevirapine) FDA Prescribing Information</a> <a href="javascript:if(confirm('https://web.archive.org/web/20161108141845/http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201152s004lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161108141845/http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201152s004lbl.pdf'" tppabs="https://web.archive.org/web/20161108141845/http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201152s004lbl.pdf" class="external text external">Archived</a><span> 2016-11-08 at the </span>Wayback Machine</span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite id="CITEREFSternRobinsonLoveLanes2003" class="citation journal cs1">Stern JO, Robinson PA, Love J, Lanes S, Imperiale MS, Mayers DL (2003). "A comprehensive hepatic safety analysis of nevirapine in different populations of HIV-infected patients". <i>J Acquir Immune Defic Syndr</i>. <b>34</b> (Suppl 1): S21–S33. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00126334-200309011-00005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00126334-200309011-00005'" tppabs="https://doi.org/10.1097%2F00126334-200309011-00005" class="external text external">10.1097/00126334-200309011-00005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14562855  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14562855'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14562855" class="external text external">14562855</a>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFWitKesselringGras2008" class="citation journal cs1">Wit FW, Kesselring AM, Gras L (Mar 2008). <a href="javascript:if(confirm('https://doi.org/10.1086/528861  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086/528861'" tppabs="https://doi.org/10.1086/528861" class="external text external">"Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: the ATHENA cohort study"</a>. <i>Clin Infect Dis</i>. <b>46</b> (6): 933–40. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1086%2F528861  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086%2F528861'" tppabs="https://doi.org/10.1086%2F528861" class="external text external">10.1086/528861</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18271750  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18271750'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18271750" class="external text external">18271750</a>.</cite></span></li><li id="cite_note-:02-26"> <span id="mw-reference-text-cite_note-:02-26" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201152s004lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201152s004lbl.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201152s004lbl.pdf" class="external text external">"VIRAMUNE® (nevirapine) Prescribing Information"</a> <span class="cs1-format">(PDF)</span>. <a href="javascript:if(confirm('https://web.archive.org/web/20161108141845/http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201152s004lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161108141845/http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201152s004lbl.pdf'" tppabs="https://web.archive.org/web/20161108141845/http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201152s004lbl.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 2016-11-08.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFWenkTodescoKrähenbühl2004" class="citation journal cs1">Wenk M, Todesco L, Krähenbühl S (2004). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884478  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884478'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884478" class="external text external">"Effect of St John's wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females"</a>. <i>Br J Clin Pharmacol</i>. <b>57</b> (4): 495–499. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-2125.2003.02049.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-2125.2003.02049.x'" tppabs="https://doi.org/10.1111%2Fj.1365-2125.2003.02049.x" class="external text external">10.1111/j.1365-2125.2003.02049.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884478  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884478'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884478" class="external text external">1884478</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15025748  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15025748'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15025748" class="external text external">15025748</a>.</cite></span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><cite id="CITEREFPatelBenfield1996" class="citation journal cs1">Patel SS, Benfield P (Oct 1996). "New drug profile: nevirapine". <i>Clinical Immunotherapeutics</i>. <b>6</b> (4): 307–317. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2FBF03259093  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2FBF03259093'" tppabs="https://doi.org/10.1007%2FBF03259093" class="external text external">10.1007/BF03259093</a>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite id="CITEREFSchauerHuberLeubaSluis-Cremer2014" class="citation journal cs1">Schauer, Grant D.; Huber, Kelly D.; Leuba, Sanford H.; Sluis-Cremer, Nicolas (2014-10-13). <a href="javascript:if(confirm('http://nar.oxfordjournals.org/content/42/18/11687  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://nar.oxfordjournals.org/content/42/18/11687'" tppabs="http://nar.oxfordjournals.org/content/42/18/11687" class="external text external">"Mechanism of allosteric inhibition of HIV-1 reverse transcriptase revealed by single-molecule and ensemble fluorescence"</a>. <i>Nucleic Acids Research</i>. <b>42</b> (18): 11687–11696. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Fnar%2Fgku819  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fnar%2Fgku819'" tppabs="https://doi.org/10.1093%2Fnar%2Fgku819" class="external text external">10.1093/nar/gku819</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0305-1048  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0305-1048'" tppabs="https://www.worldcat.org/issn/0305-1048" class="external text external">0305-1048</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191400  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191400'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191400" class="external text external">4191400</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25232099  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25232099'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25232099" class="external text external">25232099</a>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite id="CITEREFRenBirdChamberlainStewart-Jones2002" class="citation journal cs1">Ren J, Bird LE, Chamberlain PP, Stewart-Jones GB, Stuart DI, Stammers DK (Oct 2002). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137897  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137897'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137897" class="external text external">"Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors"</a>. <i>Proc Natl Acad Sci USA</i>. <b>99</b> (22): 14410–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1073%2Fpnas.222366699  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1073%2Fpnas.222366699'" tppabs="https://doi.org/10.1073%2Fpnas.222366699" class="external text external">10.1073/pnas.222366699</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137897  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137897'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137897" class="external text external">137897</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12386343  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12386343'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12386343" class="external text external">12386343</a>.</cite></span></li><li id="cite_note-31"> <span id="mw-reference-text-cite_note-31" class="mw-reference-text"><cite id="CITEREFConwayWainbergHall2001" class="citation journal cs1">Conway B, Wainberg MA, Hall D (Jul 2001). "Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine". <i>AIDS</i>. <b>15</b> (10): 1269–74. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00002030-200107060-00008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00002030-200107060-00008'" tppabs="https://doi.org/10.1097%2F00002030-200107060-00008" class="external text external">10.1097/00002030-200107060-00008</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11426071  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11426071'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11426071" class="external text external">11426071</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/nevirapine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/nevirapine'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/nevirapine" class="external text external">"Nevirapine"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Antiviral_drugs:_antiretroviral_drugs_used_against_HIV_(primarily_J05)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antiviral_drugs:_antiretroviral_drugs_used_against_HIV_(primarily_J05)" style="font-size:114%;margin:0 4em">Antiviral drugs: antiretroviral drugs used against HIV (primarily J05)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Entry/fusion inhibitors <br> <i>(Discovery and development)</i></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>gp41</i> (<a href="Enfuvirtide.htm" tppabs="https://ptable.com/wiki/compounds/A/Enfuvirtide" title="Enfuvirtide">Enfuvirtide (ENF, T-20)</a>)</li>
<li><i>CCR5</i> (<a href="Maraviroc.htm" tppabs="https://ptable.com/wiki/compounds/A/Maraviroc" title="Maraviroc">Maraviroc (MVC)</a></li>
<li>Vicriviroc<sup>†</sup>, Cenicriviroc<sup>†</sup>, PRO 140<sup>†</sup>)</li>
<li><i>CD4</i> (Ibalizumab<sup>†</sup>, UB421<sup>§</sup>)</li>
<li><i>gp120</i> (Fostemsavir)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Reverse-transcriptase<br> inhibitors (RTIs)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Nucleoside and<br> nucleotide (NRTI)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Nucleoside analogues/NRTIs:</i>  <a href="Abacavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Abacavir" title="Abacavir">Abacavir (ABC)</a>°<sup>#</sup></li>
<li><a href="Didanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Didanosine" title="Didanosine">Didanosine (ddI)</a></li>
<li><a href="Emtricitabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Emtricitabine" title="Emtricitabine">Emtricitabine (FTC)</a>°</li>
<li><a href="Lamivudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamivudine" title="Lamivudine">Lamivudine (3TC)</a>°<sup>#</sup></li>
<li><a href="Stavudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Stavudine" title="Stavudine">Stavudine (d4T)</a><sup>#</sup></li>
<li><a href="Zidovudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Zidovudine" title="Zidovudine">Zidovudine (AZT, ZDV)</a><sup>#</sup></li>
<li>Amdoxovir<sup>†</sup></li>
<li>Apricitabine<sup>†</sup></li>
<li>Censavudine<sup>†</sup></li>
<li>Elvucitabine<sup>†</sup></li>
<li>Islatravir (EFdA)<sup>§</sup></li>
<li>Racivir<sup>†</sup></li>
<li>Stampidine<sup>†</sup></li>
<li><a href="Zalcitabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Zalcitabine" title="Zalcitabine">Zalcitabine (ddC)</a><sup>◊</sup></li></ul>

<ul><li><i>Nucleotide analogues/NtRTIs:</i>  Tenofovir disoproxil (TDF)°<sup>#</sup></li>
<li>Tenofovir alafenamide (TAF)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Non-nucleoside (NNRTI)<br><i>(Discovery and development)</i></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">1<sup>st</sup> generation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz (EFV)</a>°<sup>#</sup></li>
<li><a href="Nevirapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nevirapine" title="Nevirapine">Nevirapine (NVP)</a><sup>#</sup></li>
<li><a href="Delavirdine.htm" tppabs="https://ptable.com/wiki/compounds/A/Delavirdine" title="Delavirdine">Delavirdine (DLV)</a><sup>◊</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">2<sup>nd</sup> generation</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>diarylpyrimidines</i>
<ul><li>Etravirine (ETR)</li>
<li>Rilpivirine (RPV)°</li></ul></li>
<li>Doravirine°</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Integrase inhibitors<br>(Integrase strand transfer inhibitors (INSTI))</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Dolutegravir (DTG)°</li>
<li>Elvitegravir (EVG)°</li>
<li>Raltegravir (RAL)°</li>
<li>BI 224436<sup>†</sup></li>
<li>Cabotegravir<sup>†</sup></li>
<li>Bictegravir (BIC)<sup>†</sup></li>
<li>MK-2048<sup>†</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Maturation inhibitors</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bevirimat<sup>†</sup></li>
<li>BMS-955176<sup>§</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Protease Inhibitors (PI)<br><i>(Discovery and development)</i></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">1<sup>st</sup> generation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amprenavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Amprenavir" title="Amprenavir">Amprenavir (APV)</a><sup>◊</sup></li>
<li><a href="Fosamprenavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosamprenavir" title="Fosamprenavir">Fosamprenavir (FPV)</a></li>
<li><a href="Indinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Indinavir" title="Indinavir">Indinavir (IDV)</a><sup>◊</sup></li>
<li><a href="Lopinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Lopinavir" title="Lopinavir">Lopinavir (LPV)</a></li>
<li><a href="Nelfinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Nelfinavir" title="Nelfinavir">Nelfinavir (NFV)</a></li>
<li><a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">Ritonavir (RTV)</a><sup>#</sup></li>
<li><a href="Saquinavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Saquinavir" title="Saquinavir">Saquinavir (SQV)</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">2<sup>nd</sup> generation</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Atazanavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Atazanavir" title="Atazanavir">Atazanavir (ATV)</a>°<sup>#</sup></li>
<li><a href="Darunavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Darunavir" title="Darunavir">Darunavir (DRV)</a>°<sup>#</sup></li>
<li><a href="Tipranavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Tipranavir" title="Tipranavir">Tipranavir (TPV)</a></li>
<li>TMC-310911<sup>§</sup></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Combined formulations</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Abacavir/lamivudine°<sup>#</sup></li>
<li>Abacavir/dolutegravir/lamivudine°</li>
<li>Abacavir/lamivudine/zidovudine</li>
<li>Atazanavir/cobicistat</li>
<li>Bictegravir/emtricitabine/tenofovir alafenamide</li>
<li>Darunavir/cobicistat</li>
<li>Darunavir/cobicistat/emtricitabine/tenofovir alafenamide</li>
<li>Dolutegravir/lamivudine</li>
<li>Dolutegravir/lamivudine/tenofovir</li>
<li>Dolutegravir/rilpivirine</li>
<li>Doravirine/lamivudine/tenofovir</li>
<li>Efavirenz/emtricitabine/tenofovir°<sup>#</sup></li>
<li>Efavirenz/lamivudine/tenofovir<sup>#</sup></li>
<li>Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide</li>
<li>Elvitegravir/cobicistat/emtricitabine/tenofovir°</li>
<li>Emtricitabine/tenofovir alafenamide</li>
<li>Emtricitabine/rilpivirine/tenofovir alafenamide</li>
<li>Emtricitabine/rilpivirine/tenofovir°</li>
<li>Emtricitabine/tenofovir°<sup>#</sup></li>
<li>Lamivudine/nevirapine/stavudine<sup>#</sup></li>
<li>Lamivudine/nevirapine/zidovudine<sup>#</sup></li>
<li>Lamivudine/raltegravir</li>
<li>Lamivudine/tenofovir</li>
<li>Lamivudine/zidovudine<sup>#</sup></li>
<li>Lopinavir/ritonavir°<sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Pharmacokinetic boosters</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cobicistat (c)</li>
<li><a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">Ritonavir (r)</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Experimental agents</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Uncoating inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>TRIM5alpha (gene)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Transcription inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Tat antagonists</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Translation inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Trichosanthin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"> BNAbs</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Elipovimab</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Abzyme</li>
<li>BIT225<sup>†</sup></li>
<li>Calanolide A</li>
<li>Ceragenin</li>
<li>Cyanovirin-N</li>
<li>Diarylpyrimidines</li>
<li><a href="Epigallocatechin_gallate.htm" tppabs="https://ptable.com/wiki/compounds/A/Epigallocatechin_gallate" title="Epigallocatechin gallate">Epigallocatechin gallate (EGCG)</a></li>
<li><a href="Foscarnet.htm" tppabs="https://ptable.com/wiki/compounds/A/Foscarnet" title="Foscarnet">Foscarnet</a></li>
<li>Fosdevirine<sup>†</sup></li>
<li>Griffithsin</li>
<li><a href="Hydroxycarbamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxycarbamide" title="Hydroxycarbamide">Hydroxycarbamide</a></li>
<li>KP-1461<sup>†</sup></li>
<li><a href="Miltefosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Miltefosine" title="Miltefosine">Miltefosine</a></li>
<li>Portmanteau inhibitors</li>
<li>Scytovirin</li>
<li>Seliciclib<sup>†</sup></li>
<li>Synergistic enhancers</li>
<li>Tre recombinase</li>
<li>Zinc finger protein transcription factor</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Failed agents</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Aplaviroc</li>
<li>Atevirdine</li>
<li>Brecanavir</li>
<li>Capravirine</li>
<li>Dexelvucitabine</li>
<li>Droxinavir</li>
<li>Lasinavir</li>
<li>Emivirine</li>
<li>Lersivirine</li>
<li>Lodenosine</li>
<li>Loviride</li>
<li>Mozenavir</li>
<li><span class="new">Palinavir</span></li>
<li><span class="new">Telinavir</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div> °DHHS <i>recommended</i> initial regimen options. <sup>◊</sup>Formerly or rarely used agent.<br></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Xenobiotic-sensing_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Xenobiotic-sensing_receptor_modulators" style="font-size:114%;margin:0 4em">Xenobiotic-sensing receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>CAR</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">6,7-Dimethylesculetin</span></li>
<li><a href="Amiodarone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiodarone" title="Amiodarone">Amiodarone</a></li>
<li><a href="Artemisinin.htm" tppabs="https://ptable.com/wiki/compounds/A/Artemisinin" title="Artemisinin">Artemisinin</a></li>
<li><span class="new">Benfuracarb</span></li>
<li><a href="Carbamazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbamazepine" title="Carbamazepine">Carbamazepine</a></li>
<li><a href="Carvedilol.htm" tppabs="https://ptable.com/wiki/compounds/A/Carvedilol" title="Carvedilol">Carvedilol</a></li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="Chrysin.htm" tppabs="https://ptable.com/wiki/compounds/A/Chrysin" title="Chrysin">Chrysin</a></li>
<li><span class="new">CITCO</span></li>
<li><a href="Clotrimazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Clotrimazole" title="Clotrimazole">Clotrimazole</a></li>
<li><a href="Cyclophosphamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclophosphamide" title="Cyclophosphamide">Cyclophosphamide</a></li>
<li><a href="Cypermethrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cypermethrin" title="Cypermethrin">Cypermethrin</a></li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a> (prasterone)</li>
<li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li><a href="Ellagic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Ellagic_acid" title="Ellagic acid">Ellagic acid</a></li>
<li><a href="Griseofulvin.htm" tppabs="https://ptable.com/wiki/compounds/A/Griseofulvin" title="Griseofulvin">Griseofulvin</a></li>
<li><a href="Methoxychlor.htm" tppabs="https://ptable.com/wiki/compounds/A/Methoxychlor" title="Methoxychlor">Methoxychlor</a></li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li><a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li><a href="Nevirapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nevirapine" title="Nevirapine">Nevirapine</a></li>
<li><a href="Nicardipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicardipine" title="Nicardipine">Nicardipine</a></li>
<li><span class="new">Octicizer</span></li>
<li><a href="Permethrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Permethrin" title="Permethrin">Permethrin</a></li>
<li><a href="Phenobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenobarbital" title="Phenobarbital">Phenobarbital</a></li>
<li><a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">Phenytoin</a></li>
<li>Pregnanedione (5β-dihydroprogesterone)</li>
<li><a href="Reserpine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reserpine" title="Reserpine">Reserpine</a></li>
<li><span class="new">TCPOBOP</span></li>
<li><a href="Telmisartan.htm" tppabs="https://ptable.com/wiki/compounds/A/Telmisartan" title="Telmisartan">Telmisartan</a></li>
<li><a href="Tolnaftate.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolnaftate" title="Tolnaftate">Tolnaftate</a></li>
<li><a href="Troglitazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Troglitazone" title="Troglitazone">Troglitazone</a></li>
<li><a href="Valproic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproic_acid" title="Valproic acid" class="mw-redirect">Valproic acid</a></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">3,17β-Estradiol</span></li>
<li><span class="new">3α-Androstanol</span></li>
<li>3α-Androstenol</li>
<li><span class="new">3β-Androstanol</span></li>
<li><span class="new">17-Androstanol</span></li>
<li><a href="Allyl_isothiocyanate.htm" tppabs="https://ptable.com/wiki/compounds/A/Allyl_isothiocyanate" title="Allyl isothiocyanate">AITC</a></li>
<li>Ethinylestradiol</li>
<li>Meclizine</li>
<li><span class="new">Nigramide J</span></li>
<li><a href="Okadaic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Okadaic_acid" title="Okadaic acid">Okadaic acid</a></li>
<li>PK-11195</li>
<li><span class="new">S-07662</span></li>
<li><span class="new">T-0901317</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>PXR</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> 17α-Hydroxypregnenolone</li>
<li>17α-Hydroxyprogesterone</li>
<li><a href="Androstenedione.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%944-Androstenedione" title="Δ4-Androstenedione" class="mw-redirect">Δ<sup>4</sup>-Androstenedione</a></li>
<li><a href="Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%945-Androstenediol" title="Δ5-Androstenediol" class="mw-redirect">Δ<sup>5</sup>-Androstenediol</a></li>
<li>Δ<sup>5</sup>-Androstenedione</li>
<li><span class="new">AA-861</span></li>
<li>Allopregnanediol</li>
<li><a href="5α-Dihydroprogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/5%CE%B1-Dihydroprogesterone" title="5α-Dihydroprogesterone">Allopregnanedione (5α-dihydroprogesterone)</a></li>
<li><a href="Allopregnanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Allopregnanolone" title="Allopregnanolone">Allopregnanolone (brexanolone)</a></li>
<li>Alpha-Lipoic acid</li>
<li>Ambrisentan</li>
<li>AMI-193</li>
<li>Amlodipine besylate</li>
<li>Antimycotics</li>
<li><a href="Artemisinin.htm" tppabs="https://ptable.com/wiki/compounds/A/Artemisinin" title="Artemisinin">Artemisinin</a></li>
<li><a href="Aurothioglucose.htm" tppabs="https://ptable.com/wiki/compounds/A/Aurothioglucose" title="Aurothioglucose">Aurothioglucose</a></li>
<li>Bile acids</li>
<li><a href="Bithionol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bithionol" title="Bithionol">Bithionol</a></li>
<li><a href="Bosentan.htm" tppabs="https://ptable.com/wiki/compounds/A/Bosentan" title="Bosentan">Bosentan</a></li>
<li><span class="new">Bumecaine</span></li>
<li>Cafestol</li>
<li><a href="Cephaloridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cephaloridine" title="Cephaloridine">Cephaloridine</a></li>
<li><a href="Cefradine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cephradine" title="Cephradine" class="mw-redirect">Cephradine</a></li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li>Ciglitazone</li>
<li><a href="Clindamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clindamycin" title="Clindamycin">Clindamycin</a></li>
<li>Clofenvinfos</li>
<li><a href="Chloroxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chloroxine" title="Chloroxine">Chloroxine</a></li>
<li><a href="Clotrimazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Clotrimazole" title="Clotrimazole">Clotrimazole</a></li>
<li><a href="Colforsin.htm" tppabs="https://ptable.com/wiki/compounds/A/Colforsin" title="Colforsin">Colforsin</a></li>
<li><a href="Corticosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Corticosterone" title="Corticosterone">Corticosterone</a></li>
<li><a href="Cyclophosphamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclophosphamide" title="Cyclophosphamide">Cyclophosphamide</a></li>
<li>Cyproterone acetate</li>
<li><a href="Demecolcine.htm" tppabs="https://ptable.com/wiki/compounds/A/Demecolcine" title="Demecolcine">Demecolcine</a></li>
<li><a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone">Dexamethasone</a></li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a> (prasterone)</li>
<li><a href="Dehydroepiandrosterone_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone_sulfate" title="Dehydroepiandrosterone sulfate">DHEA-S</a> (prasterone sulfate)</li>
<li>Dibunate sodium</li>
<li>Diclazuril</li>
<li><a href="Dicloxacillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Dicloxacillin" title="Dicloxacillin">Dicloxacillin</a></li>
<li><a href="Dimercaprol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimercaprol" title="Dimercaprol">Dimercaprol</a></li>
<li><span class="new">Dinaline</span></li>
<li><a href="Docetaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Docetaxel" title="Docetaxel">Docetaxel</a></li>
<li>Docusate calcium</li>
<li>Dodecylbenzenesulfonic acid</li>
<li>Dronabinol</li>
<li>Droxidopa</li>
<li><a href="Vinburnine.htm" tppabs="https://ptable.com/wiki/compounds/A/Eburnamonine" title="Eburnamonine" class="mw-redirect">Eburnamonine</a></li>
<li>Ecopipam</li>
<li>Enzacamene</li>
<li>Epothilone B</li>
<li><a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">Erythromycin</a></li>
<li>Famprofazone</li>
<li><span class="new">Febantel</span></li>
<li><a href="Felodipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Felodipine" title="Felodipine">Felodipine</a></li>
<li><a href="Fenbendazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenbendazole" title="Fenbendazole">Fenbendazole</a></li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li><a href="Flucloxacillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Flucloxacillin" title="Flucloxacillin">Flucloxacillin</a></li>
<li><a href="Fluorometholone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluorometholone" title="Fluorometholone">Fluorometholone</a></li>
<li><a href="Griseofulvin.htm" tppabs="https://ptable.com/wiki/compounds/A/Griseofulvin" title="Griseofulvin">Griseofulvin</a></li>
<li>Guggulsterone</li>
<li><a href="Haloprogin.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloprogin" title="Haloprogin">Haloprogin</a></li>
<li>Hetacillin potassium</li>
<li><a href="Hyperforin.htm" tppabs="https://ptable.com/wiki/compounds/A/Hyperforin" title="Hyperforin">Hyperforin</a></li>
<li><i>Hypericum perforatum</i> (St John's wort)</li>
<li>Indinavir sulfate</li>
<li>Lasalocid sodium</li>
<li><a href="Levothyroxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levothyroxine" title="Levothyroxine">Levothyroxine</a></li>
<li><a href="Linolenic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Linolenic_acid" title="Linolenic acid">Linolenic acid</a></li>
<li><span class="new">LOE-908</span></li>
<li><a href="Loratadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loratadine" title="Loratadine">Loratadine</a></li>
<li><a href="Lovastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lovastatin" title="Lovastatin">Lovastatin</a></li>
<li>Meclizine</li>
<li><a href="Metacycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Metacycline" title="Metacycline">Metacycline</a></li>
<li><a href="Methylprednisolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylprednisolone" title="Methylprednisolone">Methylprednisolone</a></li>
<li><a href="Metyrapone.htm" tppabs="https://ptable.com/wiki/compounds/A/Metyrapone" title="Metyrapone">Metyrapone</a></li>
<li><a href="Mevastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mevastatin" title="Mevastatin">Mevastatin</a></li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li><a href="Nafcillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Nafcillin" title="Nafcillin">Nafcillin</a></li>
<li><a href="Nicardipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicardipine" title="Nicardipine">Nicardipine</a></li>
<li><a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">Nicotine</a></li>
<li><a href="Nifedipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nifedipine" title="Nifedipine">Nifedipine</a></li>
<li>Nilvadipine</li>
<li><a href="Nisoldipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nisoldipine" title="Nisoldipine">Nisoldipine</a></li>
<li>Norelgestromin</li>
<li><a href="Omeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Omeprazole" title="Omeprazole">Omeprazole</a></li>
<li><a href="Orlistat.htm" tppabs="https://ptable.com/wiki/compounds/A/Orlistat" title="Orlistat">Orlistat</a></li>
<li><a href="Oxatomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxatomide" title="Oxatomide">Oxatomide</a></li>
<li><a href="Paclitaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Paclitaxel" title="Paclitaxel">Paclitaxel</a></li>
<li><a href="Phenobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenobarbital" title="Phenobarbital">Phenobarbital</a></li>
<li><a href="Piperine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperine" title="Piperine">Piperine</a></li>
<li><a href="Plicamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Plicamycin" title="Plicamycin">Plicamycin</a></li>
<li><a href="Prednisolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednisolone" title="Prednisolone">Prednisolone</a></li>
<li><a href="Pregnanediol.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregnanediol" title="Pregnanediol">Pregnanediol</a></li>
<li>Pregnanedione (5β-dihydroprogesterone)</li>
<li>Pregnanolone</li>
<li><a href="Pregnenolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregnenolone" title="Pregnenolone">Pregnenolone</a></li>
<li>Pregnenolone 16α-carbonitrile</li>
<li>Proadifen</li>
<li><a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">Progesterone</a></li>
<li>Quingestrone</li>
<li><a href="Reserpine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reserpine" title="Reserpine">Reserpine</a></li>
<li>Reverse triiodothyronine</li>
<li><a href="Rifampicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rifampicin" title="Rifampicin">Rifampicin</a></li>
<li><a href="Rifaximin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rifaximin" title="Rifaximin">Rifaximin</a></li>
<li><a href="Rimexolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimexolone" title="Rimexolone">Rimexolone</a></li>
<li>Riodipine</li>
<li><a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">Ritonavir</a></li>
<li><a href="Simvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Simvastatin" title="Simvastatin">Simvastatin</a></li>
<li><a href="Sirolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Sirolimus" title="Sirolimus">Sirolimus</a></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li>Spiroxatrine</li>
<li><span class="new">SR-12813</span></li>
<li><span class="new">Suberoylanilide</span></li>
<li>Sulfisoxazole</li>
<li><a href="Suramin.htm" tppabs="https://ptable.com/wiki/compounds/A/Suramin" title="Suramin">Suramin</a></li>
<li><a href="Tacrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li>
<li><span class="new">Tenylidone</span></li>
<li><a href="Terconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Terconazole" title="Terconazole">Terconazole</a></li>
<li>Testosterone isocaproate</li>
<li><a href="Tetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetracycline" title="Tetracycline">Tetracycline</a></li>
<li>Thiamylal sodium</li>
<li><a href="Thiothixene.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiothixene" title="Thiothixene" class="mw-redirect">Thiothixene</a></li>
<li>Thonzonium bromide</li>
<li>Tianeptine</li>
<li><a href="Troglitazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Troglitazone" title="Troglitazone">Troglitazone</a></li>
<li><a href="Troleandomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Troleandomycin" title="Troleandomycin">Troleandomycin</a></li>
<li><span class="new">Tropanyl 3,5-dimethulbenzoate</span></li>
<li><a href="Zafirlukast.htm" tppabs="https://ptable.com/wiki/compounds/A/Zafirlukast" title="Zafirlukast">Zafirlukast</a></li>
<li><a href="Zeranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Zeranol" title="Zeranol">Zeranol</a></li></ul>

<ul><li><i>Antagonists:</i> <a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="Sesamin.htm" tppabs="https://ptable.com/wiki/compounds/A/Sesamin" title="Sesamin">Sesamin</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd><i>Receptor/signaling modulators</i></dd></dl>
</div></td></tr></tbody></table></div><span>
</span>










<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-06-19" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Nevirapine&oldid=963442884  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Nevirapine&oldid=963442884'" tppabs="https://en.wikipedia.org/wiki/?title=Nevirapine&oldid=963442884">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>